Skip to content

Augmenting Cognitive Training In Older Adults

Augmenting Cognitive Training In Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02851511
Acronym
ACT
Enrollment
379
Registered
2016-08-01
Start date
2017-08-08
Completion date
2022-04-30
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

A two-phase adaptive randomized clinical trial will examine the individual and combined impact of pairing cognitive training with transcranial direct current stimulation (tDCS). tDCS is a method of non-invasive brain stimulation that directly stimulates brain regions involved in active cognitive function and could enhance neural plasticity when paired with a training task. We will compare changes in cognitive and brain function resulting from CT and ET combined with tDCS using a comprehensive neurocognitive, clinical, and multimodal neuroimaging assessment of brain structure, function, and metabolic state. Functional magnetic resonance imaging (FMRI) will be used to assess brain response during working memory, attention, and memory encoding; the active cognitive abilities trained by CT. Proton magnetic resonance spectroscopy (MRS) will assess cerebral metabolites, including GABA concentrations sensitive to neural plasticity. We hypothesize that: 1) tDCS will enhance neurocognitive function, brain function, and functional outcomes from CT, with combined CT and tDCS providing the most benefit; 2) Effects of tDCS on CT will be maintained up to 12 months following training, and 3) Neuroimaging biomarkers of cerebral metabolism, neural plasticity (GABA concentrations) and functional brain response (FMRI) during resting vs. active cognitive tasks will predict individual response to tDCS.

Interventions

BEHAVIORALCognitive Training

Cognitive Training employs an eight component, PositScience BrainHQ suite via its researcher portal.

A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two biocarbon rubber electrodes encased in saline soaked 5cm x 7cm sponges (8cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (10-20 system).

Sham stimulation is performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure.

Educational training involves watching educational videos produced by the National Geographic Channel, which cover a range of topics such as history, nature, and wildlife. Participants will be asked to complete questions on the content of the videos to ensure sustained attention.

Sponsors

University of Arizona
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 65 to 89 years; this age group was selected because it is at high risk of age-related cognitive decline and have a sufficiently long life expectancy to participate in the study. 2. Evidence of age-related cognitive decline in the Cognitive Training assessment defined by performance below the 80th percentile. 3. Ability to participate in the intervention and attend training sessions; willingness to be randomized to either treatment group.

Exclusion criteria

1. Neurological disorders (e.g., dementia, stroke, seizures, traumatic brain injury). 2. Evidence of cognitive impairment (as defined by NACC UDS performance below 1.5 standard deviations on age/sex/education normative data in at least one cognitive domain). 3. Past opportunistic brain infection. 4. Major psychiatric illness (schizophrenia, intractable affective disorder, current substance dependence diagnosis or severe major depression and/or suicidality. 5. Unstable (e.g., cancer other than basal cell skin) and chronic (e.g. severe diabetes) medical conditions. 6. MRI contraindications (e.g., claustrophobia, metal implants). 7. Physical impairment precluding motor response or lying still for 1 hr and inability to walk two blocks without stopping. 8. Currently on GABA-ergic or glutamatergic medications, or on sodium channel blockers. 9. Left-handedness.

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Cognitive Ability.Change from baseline to post assessment (3 months).Composite measure of cognitive ability as defined by NIH toolbox fluid cognition fully corrected T-score. Minimum change = -13, Maximum change = 26. Higher scores mean a better outcome. The minimum and maximum for Cognitive Training + Active Stimulation, Cognitive Training + Sham Stimulation, Educational Training + Active Stimulation and Educational Training + Sham Stimulation are (-13, 20) and (-10, 26), respectively. This outcome is measured for the participants who received cognitive training, including both Phase I and Phase II participants, N=334 (Phase I N=42, Phase II N=292).

Secondary

MeasureTime frameDescription
Phase I POSIT BrainHQ Cognitive Training Composite Performance Measure.(Phase I POSIT Z-Score)Baseline to post assessment (3 months).POSIT BrainHQ Cognitive Training Composite Performance measure involves performance on the 8 selected cognitive training tasks set to the medium difficulty level and provides a measure of proximal performance on cognitive training tasks central to the cognitive training condition. The higher score indicates better performance. The range of POSIT Z-Score at 3-month is -1.04 to 1.75. the minimum and maximum for Cognitive training group and Education training group are (-0.24, 1.75) and (-1.04, 1.39), respectively.

Countries

United States

Participant flow

Recruitment details

Participant flow is reported with three periods. Period 1 includes all randomized participants (combined Phase I and Phase II). Period 2 contains only the Phase I participants. Period 3 contains only the Phase II participants. In Phase II the two education training arms were eliminated, hence the allocation of 0 to those groups. Participants who were enrolled in Phase I education training were not randomized again in Phase II (there is no crossover).

Participants by arm

ArmCount
Cognitive Training + Active Stimulation
This arm receives cognitive training combined with active tDCS. Cognitive Training: Cognitive Training employs an eight component, PositScience BrainHQ suite via its researcher portal. tDCS (active stimulation): A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two biocarbon rubber electrodes encased in saline soaked 5cm x 7cm sponges (8cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (10-20 system).
168
Cognitive Training + Sham Stimulation
This arm receives cognitive training combined with sham tDCS. Cognitive Training: Cognitive Training employs an eight component, PositScience BrainHQ suite via its researcher portal. tDCS (sham stimulation): Sham stimulation is performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure.
166
Educational Training + Active Stimulation
This arm receives educational training combined with active tDCS. tDCS (active stimulation): A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two biocarbon rubber electrodes encased in saline soaked 5cm x 7cm sponges (8cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (10-20 system). Educational Training: Educational training involves watching educational videos produced by the National Geographic Channel, which cover a range of topics such as history, nature, and wildlife. Participants will be asked to complete questions on the content of the videos to ensure sustained attention.
23
Educational Training + Sham Stimulation
This arm receives educational training combined with sham tDCS. tDCS (sham stimulation): Sham stimulation is performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure. Educational Training: Educational training involves watching educational videos produced by the National Geographic Channel, which cover a range of topics such as history, nature, and wildlife. Participants will be asked to complete questions on the content of the videos to ensure sustained attention.
22
Total379

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall (Phase I + Phase II)COVID-19 lockdown, no reason specified4500
Overall (Phase I + Phase II)Lost to Follow-up0100
Overall (Phase I + Phase II)Physician Decision181601
Overall (Phase I + Phase II)Withdrawal by Subject201703
Phase IPhysician Decision0001
Phase IWithdrawal by Subject2103
Phase IICOVID-19 lockdown, no reason specified4500
Phase IILost to Follow-up0100
Phase IIPhysician Decision181600
Phase IIWithdrawal by Subject181600

Baseline characteristics

CharacteristicCognitive Training + Active StimulationCognitive Training + Sham StimulationEducational Training + Active StimulationEducational Training + Sham StimulationTotal
Age, Continuous71.5 years
STANDARD_DEVIATION 5.4
71.5 years
STANDARD_DEVIATION 4.8
70.0 years
STANDARD_DEVIATION 5.1
73.1 years
STANDARD_DEVIATION 4.7
71.5 years
STANDARD_DEVIATION 5.1
Average POSIT z-score:-0.18 z-score
STANDARD_DEVIATION 0.44
-0.20 z-score
STANDARD_DEVIATION 0.46
-0.11 z-score
STANDARD_DEVIATION 0.47
-0.44 z-score
STANDARD_DEVIATION 0.55
-0.20 z-score
STANDARD_DEVIATION 0.46
BDI-II Total Score4.0 units on a scale
STANDARD_DEVIATION 4.8
3.4 units on a scale
STANDARD_DEVIATION 3.9
2.4 units on a scale
STANDARD_DEVIATION 3.1
3.1 units on a scale
STANDARD_DEVIATION 3.7
3.6 units on a scale
STANDARD_DEVIATION 4.3
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants8 Participants1 Participants2 Participants25 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
154 Participants158 Participants22 Participants20 Participants354 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
MOCA Total Score26.7 units on a scale
STANDARD_DEVIATION 2
26.8 units on a scale
STANDARD_DEVIATION 1.9
26.9 units on a scale
STANDARD_DEVIATION 1.7
26.1 units on a scale
STANDARD_DEVIATION 2.1
26.7 units on a scale
STANDARD_DEVIATION 1.9
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants5 Participants1 Participants0 Participants9 Participants
Race (NIH/OMB)
Asian
0 Participants3 Participants1 Participants0 Participants4 Participants
Race (NIH/OMB)
Black or African American
11 Participants8 Participants0 Participants2 Participants21 Participants
Race (NIH/OMB)
More than one race
5 Participants2 Participants0 Participants2 Participants9 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants0 Participants0 Participants0 Participants3 Participants
Race (NIH/OMB)
White
146 Participants148 Participants20 Participants18 Participants332 Participants
Region of Enrollment
United States
168 participants166 participants23 participants22 participants0 participants
Sex: Female, Male
Female
104 Participants111 Participants10 Participants11 Participants236 Participants
Sex: Female, Male
Male
64 Participants55 Participants13 Participants11 Participants143 Participants
Years of Education16.3 years
STANDARD_DEVIATION 2.3
16.4 years
STANDARD_DEVIATION 2.4
16.7 years
STANDARD_DEVIATION 2.1
15.6 years
STANDARD_DEVIATION 2.4
16.3 years
STANDARD_DEVIATION 2.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1680 / 1660 / 230 / 22
other
Total, other adverse events
69 / 16875 / 16612 / 2312 / 22
serious
Total, serious adverse events
16 / 16819 / 1664 / 235 / 22

Outcome results

Primary

Improvement in Cognitive Ability.

Composite measure of cognitive ability as defined by NIH toolbox fluid cognition fully corrected T-score. Minimum change = -13, Maximum change = 26. Higher scores mean a better outcome. The minimum and maximum for Cognitive Training + Active Stimulation, Cognitive Training + Sham Stimulation, Educational Training + Active Stimulation and Educational Training + Sham Stimulation are (-13, 20) and (-10, 26), respectively. This outcome is measured for the participants who received cognitive training, including both Phase I and Phase II participants, N=334 (Phase I N=42, Phase II N=292).

Time frame: Change from baseline to post assessment (3 months).

ArmMeasureValue (MEAN)Dispersion
Cognitive Training + Active StimulationImprovement in Cognitive Ability.4.7 units on a scaleStandard Deviation 6.5
Cognitive Training + Sham StimulationImprovement in Cognitive Ability.4.5 units on a scaleStandard Deviation 6.1
Comparison: Null hypothesis: The combination of cognitive training (12 weeks) and active stimulation (over the dorsolateral prefrontal cortex) will not lead to beneficial changes on the NIH Toolbox Cognition Battery.~The study is designed to have at least 90% power to detect a difference of effect size 0.42 between cognitive training+tDCS and cognitive training+sham, using a normal inverse combination test at one-sided 0.025 level.p-value: <0.0595% CI: [-0.91, 1.56]Regression, Linear
Secondary

Phase I POSIT BrainHQ Cognitive Training Composite Performance Measure.(Phase I POSIT Z-Score)

POSIT BrainHQ Cognitive Training Composite Performance measure involves performance on the 8 selected cognitive training tasks set to the medium difficulty level and provides a measure of proximal performance on cognitive training tasks central to the cognitive training condition. The higher score indicates better performance. The range of POSIT Z-Score at 3-month is -1.04 to 1.75. the minimum and maximum for Cognitive training group and Education training group are (-0.24, 1.75) and (-1.04, 1.39), respectively.

Time frame: Baseline to post assessment (3 months).

Population: Adults were between the ages of 65-89, right-handed, fluent in English, and had evidence of age-related cognitive decline. Analysis includes all 87 participants from Phase I.

ArmMeasureValue (MEAN)Dispersion
Cognitive Training + Active StimulationPhase I POSIT BrainHQ Cognitive Training Composite Performance Measure.(Phase I POSIT Z-Score)0.95 units on a scaleStandard Deviation 0.41
Cognitive Training + Sham StimulationPhase I POSIT BrainHQ Cognitive Training Composite Performance Measure.(Phase I POSIT Z-Score)-0.06 units on a scaleStandard Deviation 0.47

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026